ICU Medical, Inc. (ICUI) Stock Analysis
Recovery setup
Healthcare · Medical Instruments & Supplies
Sell if holding. Multiple concerning factors at $123.08: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Weak overall score: 4.4/10.
ICU Medical develops, manufactures, and sells infusion therapy, vascular access, and vital care medical products globally, including IV pumps, needlefree connectors, catheters, and closed system transfer devices for hazardous drugs. Revenue comes from direct sales to hospitals... Read more
Sell if holding. Multiple concerning factors at $123.08: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Weak overall score: 4.4/10. Chart setup: Death cross but MACD improving, RSI 53. Score 4.4/10, moderate confidence.
Passes 8/10 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 80d clear, semi cycle peak clear, materials cycle peak clear). Fails on death cross (50MA < 200MA). Suitability: aggressive.
Recent Developments — ICU Medical, Inc.
Latest news
- ICU Medical Earnings: What To Look For From ICUI - StockStory — StockStory neutral
- ICU Medical (ICUI) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance — Yahoo Finance positive
- ICU Medical Inc (ICUI) Stock Down 4.6% -- Now Undervalued? GF Sc - GuruFocus — GuruFocus negative
- ICU Medical, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:ICUI) 2026-05-07 - Seeking Alpha — Seeking Alpha positive
- ICU Medical (ICUI) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance — Yahoo Finance positive
Generated 2026-05-20T20:21:21Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Revenue shrinking — -12.3% YoY. Growth thesis broken unless recovery story develops.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Multiple concerning factors at $123.08: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Weak overall score: 4.4/10. Chart setup: Death cross but MACD improving, RSI 53. Prior stop was $114.46. Score 4.4/10, moderate confidence.
Take-profit target: $151.53 (+23.1% upside). Prior stop was $114.46. Stop-loss: $114.46.
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Weak overall score: 4.4/10; Weak growth.
ICU Medical, Inc. trades at a P/E of 63.8 (forward 12.7). TrendMatrix value score: 7.3/10. Verdict: Sell.
12 analysts cover ICUI with a consensus score of 4.2/5. Average price target: $174.
What does ICU Medical, Inc. do?ICU Medical develops, manufactures, and sells infusion therapy, vascular access, and vital care medical products...
ICU Medical develops, manufactures, and sells infusion therapy, vascular access, and vital care medical products globally, including IV pumps, needlefree connectors, catheters, and closed system transfer devices for hazardous drugs. Revenue comes from direct sales to hospitals and through distributors in 100+ countries, with a single distributor accounting for 18% of consolidated net sales in 2025.